Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
1(100.0%)
1Total
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03103113Completed

The Evolution of Relationship Between Results of Peripheral Blood Test and Outcomes of in Vitro Fertilization

Role: lead

NCT02622672Phase 2Completed

Water-soluble Ubiquinol Supplementation on Blood Glucose, Lipids, Oxidative Stress, and Inflammation in Diabetes

Role: lead

NCT03065114Completed

Retrospective Study on Clinical Results of Preimplantation Genetic Screening at Different Embryo Stage

Role: lead

All 3 trials loaded